Author:
Revin V. V.,Balykova L. A.,Radaeva O. A.,Shchapov V. V.,Revina E. S.,Pinyaev S. I.,Kostina Yu. A.,Kozlov E. D.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Kuznetsova EE, Gorokhova VG, Koryakina LB, Babushkina IV. Some aspects of the estimation of structuralfunctional changes in membrane of erythrocytes at the cardiovascular pathology. Acta Biomedica Scientifica. 2012;(4-1):236-240.
2. Ushakova AA, Gromova NV, Revin VV, Mel’nikova NA, Revina ES, Martynova MI, Tyutyaev EV. the study of oxygen-binding properties of hemoglobin in erythrocytes in myocardial infarction. Arkhivarius. 2016;2(5):4-9. Russian. 3. Berzuini A, Bianco C, Migliorini AC, Maggioni M, Valenti L, Prati D. Red blood cell morphology in patients with COVID-19-related anaemia. Blood Transfus. 2021;19(1):34-36. https://doi.org/10.2450/2020.0242-20
3. Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575-e582. https://doi.org/10.1016/S2352-3026(20)30216-7
4. Johnson CS, Cook CA, Furmanski P. In vivo suppression of erythropoiesis by tumor necrosis factor-alpha (TNFalpha): reversal with exogenous erythropoietin (EPO). Exp. Hematol. 1990;18(2):109-113.
5. Kakavas S, Demestiha T, Vasileiou P, Xanthos T. Erythropoetin as a novel agent with pleiotropic effects against acute lung injury. Eur. J. Clin. Pharmacol. 2011;67(1):1-9. https://doi.org/10.1007/s00228-010-0938-7
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献